key: cord-0880559-9n1c0czb
authors: Weiler-Sagie, Michal; Half, Elizabeth E.
title: [(68)Ga]Ga-DOTA-TATE uptake due to COVID-19 vaccination
date: 2021-05-22
journal: Eur J Nucl Med Mol Imaging
DOI: 10.1007/s00259-021-05414-z
sha: a4d1395f775eebfb58d709556cc21d29e4a53692
doc_id: 880559
cord_uid: 9n1c0czb

nan

A 61-year-old female was referred to [ 68 Ga]Ga-DOTA-TATE-PET/CT for suspected neuroendocrine tumor (NET). She suffered from intractable peptic disease, and her chromogranin A had reached a level of 1447 ng/ml. There was a focus of pathological [ 68 Ga]Ga-DOTA-TATE uptake in the head of the pancreas, consistent with NET. There was increased uptake in lymphadenopathy in the left axilla and faint uptake in the left upper arm. The patient received the second dose of the Pfizer-BioNTech COVID-19 vaccine 2 days prior to the PET/CT, as an intra-muscular shot to the left deltoid. The first dose was administered 21 days prior to the second dose.

Lymphatic tissues including lymph nodes are known to express somatostatin receptors [1] , and [68]GA-DOTATATE uptake is commonly seen in reactive lymph nodes [2] . This case demonstrates [68]GA-DOTA-TATE uptake due to COVID-19 vaccination in a pattern identical to that of FDG uptake following COVID-19 vaccination [3, 4] . Nuclear medicine physicians and referring physicians should be aware of this classic pattern. History of recent vaccination localized to the site of uptake should confirm the diagnosis and obliviate the need for further testing.

This article is part of the Topical Collection on Image of the month * Michal Weiler-Sagie m_weiler@rmc.gov.il

In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue

Neuroendocrine tumor imaging with 68Ga-DOTA-NOC: physiologic and benign variants

Imaging of COVID-19 vaccination at FDG PET/ CT

COVID-19 vaccination induced axillary nodal uptake on [18F]FDG PET/CT